Steven Cohen's OBIO Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 0 shares of Orchestra BioMed Holdings, Inc. (OBIO) worth $0, representing 0.00% of the portfolio. First purchased in 2025-Q4, this short-term holding has been held for 3 quarters.
Based on 13F filings, Steven Cohen has maintained this position in OBIO for several quarters, showing initial confidence in the investment. Largest reduction occurred in Q2 2026, reducing 87,888 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Orchestra BioMed Holdings (OBIO) Holding Value Over Time
Track share changes against reported price movement
Quarterly Orchestra BioMed Holdings (OBIO) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | -87,888 | Sold Out | 0 | $0.00 |
| Q1 2026 | -74,058 | Reduce 45.73% | 87,888 | $4.25 |
| Q4 2025 | +161,946 | New Buy | 161,946 | $4.15 |
Steven Cohen's Orchestra BioMed Holdings Investment FAQs
Steven Cohen first purchased Orchestra BioMed Holdings, Inc. (OBIO) in Q4 2025, acquiring 161,946 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Orchestra BioMed Holdings, Inc. (OBIO) for 3 quarters since Q4 2025.
Steven Cohen's largest addition to Orchestra BioMed Holdings, Inc. (OBIO) was in Q4 2025, adding 161,946 shares worth $672,076.
According to the latest 13F filing for Q2 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 0 shares of Orchestra BioMed Holdings, Inc. (OBIO), valued at approximately $0.
As of the Q2 2026 filing, Orchestra BioMed Holdings, Inc. (OBIO) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Orchestra BioMed Holdings, Inc. (OBIO) was 161,946 shares, as reported at the end of Q4 2025.